12:00 AM
 | 
Jun 17, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AUT00063: Phase I started

Autifony began a placebo-controlled, U.K. Phase I trial to evaluate single and multiple ascending-doses of oral AUT00063 in about 60 healthy volunteers....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >